Table 2.
Symptoms and Physical Examination Upon Admission
| All cohort | Matched-cohort | |||||
|---|---|---|---|---|---|---|
| CS | CS+TCZ | p value | CS | CS+TCZ | p value | |
| Cough, n (%) | 3677 (69) | 485 (79.8) | <0.001 | 434 (71.5) | 485 (79.8) | 0.001 |
| Arthromyalgias, n (%) | 1425 (26.7) | 211 (34.7) | <0.001 | 182 (30) | 211 (34.7) | 0.079 |
| Ageusia, n (%) | 574 (10.8) | 71 (11.7) | 0.493 | 88 (14.5) | 71 (11.7) | 0.145 |
| Anosmia, n (%) | 484 (9.1) | 68 (11.2) | 0.090 | 69 (11.4) | 68 (11.2) | 0.920 |
| Sore throat, n (%) | 428 (8) | 72 (11.8) | 0.001 | 69 (11.4) | 72 (11.8) | 0.796 |
| Headache, n (%) | 608 (11.4) | 96 (15.8) | 0.002 | 74 (12.2) | 96 (15.8) | 0.071 |
| Fever, n (%) | 4118 (77.2) | 523 (86) | <0.001 | 505 (83.2) | 523 (86) | 0.173 |
| Dyspnea, n (%) | 3625 (68) | 433 (71.2) | 0.105 | 434 (71.5) | 433 (71.2) | 0.913 |
| Diarrhea, n (%) | 1231 (23.1) | 181 (29.8) | <0.001 | 163 (26.9) | 181 (29.8) | 0.259 |
| Vomiting, n (%) | 360 (6.8) | 44 (7.2) | 0.653 | 42 (6.9) | 44 (7.2) | 0.829 |
| Abdominal pain, n (%) | 285 (5.3) | 34 (5.6) | 0.798 | 30 (4.9) | 34 (5.6) | 0.612 |
| Heart rate, bpm median [IQR] | 87 [76–100] | 91 [80–104] | <0.001 | 90 [80–101] | 91 [80–104] | 0.079 |
| Respiratory rate >20 rpm, n (%) | 2109 (39.6) | 328 (53.9) | <0.001 | 314 (51.7) | 328 (53.9) | 0.439 |
IQR interquartile range, CS corticosteroids, CS+TCZ corticosteroids + tocilizumab